Home > Inhibitors & Agonists

Inhibitors & Agonists

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC4947 Stk-22 Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor
DCC4948 Stk295900 Dual inhibitor of topoisomerase 1 and 2, inducing G(2) arrest in the absence of DNA damage. Inhibitor of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay
DCC4949 Stk508411 Novel inhibitor of the heterogeneous ribonuclear protein A18 (hnRNP A18)
DCC4950 Stk630921 Novel blocker of IL-17A binding to the IL-17A receptor (IL-17RA)
DCC4951 Stk683963 Novel activator of cellular ATG4B activity
DCC4952 Stock1n-65837 Potent natural modulator of human Toll-like receptor 7 (TLR7)
DCC4953 Streptolidine Metablite of the Streptomyces antibiotics streptothricin and streptolin
DCC4954 Streptozocin Antibiotic, being used as an antineoplastic agent and to induce diabetes in experimental animals
DCC4955 Sts-e412 The first nonpeptidyl, selective activator of the tissue-protective EPOR/CD131 receptor
DCC4956 Sts-e424 Novel agonist of the tissue-protective erythropoietin (EPO) receptor, increasing FXN expression and EPOR phosphorylation
DCC4957 Stx-2622 Inhibitor of 17β-hydroxysteroid dehydrogenases (17β-HSDs)
DCC4958 Stx2845 Novel Nonsteroidal Inhibitor of Carbonic Anhydrase IX
DCC4959 Su0383 Novel dual Inhibitor of repair enzymes 8-oxoguanine DNA glycosylase (OGG1) and human MutT Homolog 1 (NUDT1 or MTH1), increasing sensitivity of tumor cells to oxidative stress
DCC4960 Su11272 Novel potent c-MET inhibitor
DCC4961 Su11606 Potent c-MET inhibitor
DCC4962 Su11652 Sunitinib analog, acting as a potential inhibitor for nucleoside diphosphate kinase (NDK) from Leishmania major (LmNDK)
DCC4963 Su-200 Agonist of TRPV1
DCC4964 Su9518 Novel potent and selective inhibitor of the cellular PDGF receptor kinase and PDGF receptor-induced cell proliferation
DCC4965 Subglutinol A Natural immunosuppressive agent, effectively blocking T cell proliferation and survival while profoundly inhibiting pro-inflammatory IFNγ and IL-17 production by fully differentiated effector Th1 and Th17 cells, also acting as an estrogen receptor antagon
DCC4966 Suc-leu-leu-val-tyr-amc Fluorescent substrate which can be hydrolyzed by the proteasome to release free AMC and the fluorescence of which is proportional to the proteasome activity
DCC4967 Sucnr1-in-20 Featured SUCNR1-IN-2 (Statement 35) is a succinate/succinate receptor 1 inhibitor for the study of neurodegenerative diseases such as neuroinflammation.
DCC4968 Suku-33 Novel potent inhibitor of osteoclastogenesis, suppressing both equilibrative nucleoside transporters and concentrative nucleoside transporters
DCC4969 Sul-121 Hydrochloride Novel inhibitor of airway inflammation and hyperresponsiveness in experimental models of chronic obstructive pulmonary disease (COPD)
DCC4970 Sulfacetamide Antibacterial, inhibiting bacterial folic acid synthesis by competing with para amino benzoic acid
DCC4971 Sulfazecin β-Lactam antibiotic against multi-drug resistant pathogens
DCC4972 Sulfonyl Quinoxaline 1 Novel inhibitor of RhoG-hepcidin uptake
DCC4973 Sulfosuccinimidyl Oleate Sodium Neuroprotective agent, alleviating stroke-induced neuroinflammation
DCC4974 Suloctidil Hydrochloride Peripheral vasodilator
DCC4975 Sulukast Novel, potent, selective, and competitive antagonist of LTD4 and LTE4
DCC4976 Sumanirole D2 selective dopamine agonist, showing anxiolytic and anti-parkinsonian activities

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X
>